Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Safety, tolerability and efficacy of BI 655066 in male and female patients with moderate to severe psoriasis.
Epistemonikos ID: fb61dd1af207f8b650f75d846c9cec105f1fe51d
First added on: May 10, 2024